Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03174275 · MORE INFO

Limitations, agreements, and source contact

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma · Source last updated 2026-02-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
other Details
Results should be deferred until published.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
jared_weiss@med.unc.edu
organization
University of North Carolina Lineberger Comprehensive Cancer Center
phone
+1 919-843-7718
title
Dr. Jared Weiss
Complete source fields
certain Agreement
other Details
Results should be deferred until published.
pi Sponsor Employee
false
restriction Type
OTHER
restrictive Agreement
true
point Of Contact
email
jared_weiss@med.unc.edu
organization
University of North Carolina Lineberger Comprehensive Cancer Center
phone
+1 919-843-7718
title
Dr. Jared Weiss

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice